Michael Roggendorf

Hepatitis B virus suppresses toll-like receptor–mediated innate immune responses in murine parenchymal and nonparenchymal liver cells #

Jun Wu, Zhongji Meng, Min Jiang et al. · Hepatology · 2008 · 315 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice

Jun Wu, Mengji Lu, Zhongji Meng et al. · Hepatology · 2007 · 273 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial

Michel Bazinet, Victor Pântea, Valentin Cebotarescu et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 249 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11

Enhancing Virus-Specific Immunity In Vivo by Combining Therapeutic Vaccination and PD-L1 Blockade in Chronic Hepadnaviral Infection

Jia Liu, Ejuan Zhang, Zhiyong Ma et al. · PLoS Pathogens · 2014 · 248 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Toll‐like receptor‐induced innate immune responses in non‐parenchymal liver cells are cell type‐specific

Jun Wu, Zhongji Meng, Min Jiang et al. · Immunology · 2009 · 210 citations · Full text

Life Sciences, Immunology, Molecular Biology +17